Scintigraphic assessment of myocardial metabolism of fatty acids using 123 I-iodophen

Experimental and clinical investigations of a new radiopharmdrug 123I-Iodophen aimed at assessing myocardial metabolism of fatty acids were performed. The results of the experiment revealed that biological behavior of the drug is characteristic of its rather marked accumulation in the heart. Clinical studies results demonstrated that tomography using the drug allows to judge about presence of viable myocardium but complex assessment of perfusion and metabolism is needed.